NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression

Margit A. Huber(Research Institute of Molecular Pathology), Ninel Azoitei(Universität Ulm), Bernd Baumann(Universität Ulm), Stefan Grünert(Research Institute of Molecular Pathology), Andreas Sommer(Research Institute of Molecular Pathology), Hubert Pehamberger(Medical University of Vienna), Norbert Kraut(Boehringer Ingelheim (Austria)), Hartmut Beug(Research Institute of Molecular Pathology), Thomas Wirth(Universität Ulm)
Journal of Clinical Investigation
August 16, 2004
Cited by 837Open Access
Full Text

Abstract

The transcription factor NF-B is activated in a range of human cancers and is thought to promote tumorigenesis, mainly due to its ability to protect transformed cells from apoptosis. To investigate the role of NF-B in epithelial plasticity and metastasis, we utilized a well-characterized in vitro/in vivo model of mammary carcinogenesis that depends on the collaboration of the Ha-Ras oncoprotein and TGF-. We show here that the IKK-2/IB/NF-B pathway is required for the induction and maintenance of epithelial-mesenchymal transition (EMT). Inhibition of NF-B signaling prevented EMT in Ras-transformed epithelial cells, while activation of this pathway promoted the transition to a mesenchymal phenotype even in the absence of TGF-. Furthermore, inhibition of NF-B activity in mesenchymal cells caused a reversal of EMT, suggesting that NF-B is essential for both the induction and maintenance of EMT. In line with the importance of EMT for invasion, blocking of NF-B activity abrogated the metastatic potential of mammary epithelial cells in a mouse model system. Collectively, these data provide evidence of an essential role for NF-B during distinct steps of breast cancer progression and suggest that the cooperation of Ras-and TGF--dependent signaling pathways in late-stage tumorigenesis depends critically on NF-B activity.


Related Papers

No related papers found

Powered by citation graph analysis